Ann: Makuutu Rare Earths Project Scoping Study, page-193

That's exactly what S2F has adjusted for above, suggest you re-read it. I was just making a generalised statement that in DCF terms it gets discounted a lot past year 10 (which is true), but I hadn't actually added it up, my guess was that it might add half of what S2F came to but that was just a guess not a worked number, and that the ramp-up curve moving to 18 months would add something similar. Most of the DCFs I've done are on more flat-line benefit curves, not one that has a 5x benefit at Y10 compared to Y1, so my mental guesstimates didn't quite work.

Re rehab, since it will be a "continuous rehabilitation" approach I would think that's part of process OPEX costs, certainty a question worth clarification but rehab is definitely covered multiple times within the doc to it has to flow to one of the cost buckets.